163 related articles for article (PubMed ID: 31669459)
1. Eighteen‑carbon trans fatty acids and inflammation in the context of atherosclerosis.
Valenzuela CA; Baker EJ; Miles EA; Calder PC
Prog Lipid Res; 2019 Oct; 76():101009. PubMed ID: 31669459
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive toxicological analysis of trans-fatty acids (TFAs) reveals a pro-apoptotic action specific to industrial TFAs counteracted by polyunsaturated FAs.
Hirata Y; Kashiwabara N; Nada Y; Inoue A; Sato E; Noguchi T; Matsuzawa A
Sci Rep; 2023 Apr; 13(1):5883. PubMed ID: 37041254
[TBL] [Abstract][Full Text] [Related]
3. Trans fat involvement in cardiovascular disease.
Ganguly R; Pierce GN
Mol Nutr Food Res; 2012 Jul; 56(7):1090-6. PubMed ID: 22760981
[TBL] [Abstract][Full Text] [Related]
4. Differential Effects of Ruminant and Industrial 18-Carbon
Valenzuela CA; Baker EJ; De Souza CO; Miles EA; Calder PC
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641380
[TBL] [Abstract][Full Text] [Related]
5. Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort.
Prada M; Wittenbecher C; Eichelmann F; Wernitz A; Kuxhaus O; Kröger J; Weikert C; Schulze MB
Diabetes Care; 2022 Apr; 45(4):845-853. PubMed ID: 35129607
[TBL] [Abstract][Full Text] [Related]
6. Trans fatty acids - effects on systemic inflammation and endothelial function.
Mozaffarian D
Atheroscler Suppl; 2006 May; 7(2):29-32. PubMed ID: 16713393
[TBL] [Abstract][Full Text] [Related]
7. [Molecular Mechanisms Underlying Toxic Actions of trans-Fatty Acids and Prevention of Related Diseases].
Matsuzawa A
Yakugaku Zasshi; 2021; 141(5):675-679. PubMed ID: 33952751
[TBL] [Abstract][Full Text] [Related]
8. Industrially produced trans-fatty acids are potent promoters of DNA damage-induced apoptosis.
Hirata Y; Kojima R; Ashida R; Nada Y; Kimura S; Sato E; Noguchi T; Matsuzawa A
J Toxicol Sci; 2024; 49(1):27-36. PubMed ID: 38191191
[TBL] [Abstract][Full Text] [Related]
9. Dietary intake of trans fatty acids and breast cancer risk in 9 European countries.
Matta M; Huybrechts I; Biessy C; Casagrande C; Yammine S; Fournier A; Olsen KS; Lukic M; Gram IT; Ardanaz E; Sánchez MJ; Dossus L; Fortner RT; Srour B; Jannasch F; Schulze MB; Amiano P; Agudo A; Colorado-Yohar S; Quirós JR; Tumino R; Panico S; Masala G; Pala V; Sacerdote C; Tjønneland A; Olsen A; Dahm CC; Rosendahl AH; Borgquist S; Wennberg M; Heath AK; Aune D; Schmidt J; Weiderpass E; Chajes V; Gunter MJ; Murphy N
BMC Med; 2021 Mar; 19(1):81. PubMed ID: 33781249
[TBL] [Abstract][Full Text] [Related]
10. trans-Fatty Acids as an Enhancer of Inflammation and Cell Death: Molecular Basis for Their Pathological Actions.
Hirata Y
Biol Pharm Bull; 2021; 44(10):1349-1356. PubMed ID: 34602541
[TBL] [Abstract][Full Text] [Related]
11. Study of Trans Fatty Acid Formation in Oil by Heating Using Model Compounds.
Gotoh N; Kagiono S; Yoshinaga K; Mizobe H; Nagai T; Yoshida A; Beppu F; Nagao K
J Oleo Sci; 2018 Mar; 67(3):273-281. PubMed ID: 29459509
[TBL] [Abstract][Full Text] [Related]
12. The diversity of health effects of individual trans fatty acid isomers.
Gebauer SK; Psota TL; Kris-Etherton PM
Lipids; 2007 Sep; 42(9):787-99. PubMed ID: 17694343
[TBL] [Abstract][Full Text] [Related]
13. Trans fatty acids and their role in inflammation and cardiovascular disease.
Stachowska E; Jamioł D; Chlubek D
Ann Acad Med Stetin; 2010; 56(3):30-8. PubMed ID: 22053624
[TBL] [Abstract][Full Text] [Related]
14. Dietary Intake of
Zupanič N; Hribar M; Hristov H; Lavriša Ž; Kušar A; Gregorič M; Blaznik U; Koroušić Seljak B; Golja P; Vidrih R; Žmitek K; Pravst I
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33445809
[TBL] [Abstract][Full Text] [Related]
15. Different Types of Industry-Produced and Ruminant Trans Fatty Acid Intake and Risk of Type 2 Diabetes: Findings From the NutriNet-Santé Prospective Cohort.
Wendeu-Foyet G; Bellicha A; Chajès V; Huybrechts I; Bard JM; Debras C; Srour B; Sellem L; Fezeu LK; Julia C; Kesse-Guyot E; Agaësse C; Druesne-Pecollo N; Galan P; Hercberg S; Deschasaux-Tanguy M; Touvier M
Diabetes Care; 2023 Feb; 46(2):321-330. PubMed ID: 36542554
[TBL] [Abstract][Full Text] [Related]
16. [Trans fatty acids: effects on lipoprotein metabolism and cardiovascular risk].
Attia-Skhiri N; Fournier N; Pourci ML; Paul JL
Ann Biol Clin (Paris); 2009; 67(5):517-23. PubMed ID: 19789123
[TBL] [Abstract][Full Text] [Related]
17.
Hatem O; Kaçar ÖF; Kaçar HK; Szentpéteri JL; Marosvölgyi T; Szabó É
Front Nutr; 2024; 11():1379772. PubMed ID: 38515522
[TBL] [Abstract][Full Text] [Related]
18. Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study.
Kleber ME; Delgado GE; Lorkowski S; März W; von Schacky C
Eur Heart J; 2016 Apr; 37(13):1072-8. PubMed ID: 26396230
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Impact of Ruminant Trans Fatty Acids on Human Health: Important Aspects to Consider.
Kuhnt K; Degen C; Jahreis G
Crit Rev Food Sci Nutr; 2016 Sep; 56(12):1964-80. PubMed ID: 25746671
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte trans-fatty acids, type 2 diabetes and cardiovascular risk factors in middle-aged and older Chinese individuals.
Yu DX; Sun Q; Ye XW; Pan A; Zong G; Zhou YH; Li HX; Hu FB; Lin X
Diabetologia; 2012 Nov; 55(11):2954-62. PubMed ID: 22886370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
